IDH1 and neoplasm: We did not evaluate tumor biomarkers, such as MGMT, IDH1/2, P53, EGFR, and PTEN, that are commonly related to overall survival, as these were not consistently available at the time of presentation to our institution for this study sample (2005–2015).